Skip to main content
. 2020 Oct 13;11(41):3723–3729. doi: 10.18632/oncotarget.27757

Figure 2. Overall survival curves of patients with intermediate prognosis PCa depending on the intake of melatonin (log rank test > 0.05).

Figure 2